GlassScriptPhysician profile
Talal Chatila
NPI 1952321846
$30,224.45
in general payments reported to CMS, 2019-2025
4 companies · $6,647 in 2025
The $6,647 reported for 2025 was more than what 82% of Pediatric Allergy/Immunology providers received nationally (typical 2025 total: $375).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.79 · 2020: $4,125 · 2024: $19K · 2025: $6,647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Food and Beverage: $360 · Travel and Lodging: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,558.00 |
| Food and Beverage | $359.66 |
| Travel and Lodging | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14,399.66 | 2020-2024 | |
| Sanofi Pasteur INC. | $13,293.00 | 2024-2025 | |
| Otsuka Pharmaceutical Co., LTD. | $2,500.00 | 2024 | |
| Genzyme Corporation | $31.79 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Talal Chatila listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.